tiprankstipranks
Trending News
More News >
Athira Pharma (ATHA)
NASDAQ:ATHA
US Market

Athira Pharma (ATHA) Income Statement

Compare
548 Followers

Athira Pharma Income Statement

Last quarter (Q4 2024), Athira Pharma's total revenue was $0.00, a decrease of -100.00% from the same quarter last year. In Q4, Athira Pharma's net income was $-15.00M. See Athira Pharma’s key income statements, including revenue, expenses, profit, and income.
Income Statement
Dec 24Dec 23Dec 22Dec 21Dec 20
Total Revenue
$ 0.00$ 0.00$ 0.00$ 0.00$ 0.00
Gross Profit
$ 0.00$ -969.00K$ -1.05M$ -479.00K$ -2.00M
Operating Expenses
$ 100.90M$ 125.47M$ 88.86M$ 55.19M$ 18.67M
Depreciation and Amortization
$ 0.00$ 969.00K$ 1.05M$ 479.00K$ 2.00M
EBITDA
$ -100.90M$ -116.70M$ -94.59M$ -54.37M$ -19.01M
Operating Income
$ -100.90M$ -125.47M$ -104.02M$ -64.02M$ -20.00M
Other Income/Expenses
$ 3.96M$ 7.79M$ 8.38M$ 9.17M$ 40.00K
Pretax Income
$ -96.94M$ -117.67M$ -95.64M$ -54.85M$ -19.95M
Net Income
$ -96.94M$ -117.67M$ -87.26M$ -54.37M$ -18.63M
Per Share Metrics
Basic EPS
$ -2.52$ -3.09$ -2.31$ -1.47$ -0.57
Diluted EPS
$ -2.52$ -3.09$ -2.31$ -1.47$ -0.57
Weighted Average Shares Outstanding
38.48M 38.02M 37.73M 36.92M 32.49M
Weighted Average Shares Outstanding (Diluted)
38.48M 38.02M 37.73M 36.92M 32.49M
Currency in USD

Athira Pharma Earnings and Revenue History

What am I Missing?
Make informed decisions based on Top Analysts' activity
Know what industry insiders are buying
Get actionable alerts from top Wall Street Analysts
Find out before anyone else which stock is going to shoot up
Get powerful stock screeners & detailed portfolio analysis